Link Reservations Inc. (LRSV) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerLink Reservations Inc. (LRSV) trades at $0.0001. Link Reservations Inc. develops and markets medicinal mushroom and cannabidiol wellness products for both humans and pets. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for LRSV: LRSV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Link Reservations Inc. (LRSV) Healthcare & Pipeline Overview
Link Reservations Inc. focuses on developing and marketing medicinal mushroom and cannabidiol wellness products for humans and pets, primarily hemp-based CBD products, in the European and United States markets, positioning itself within the specialty and generic drug manufacturing sector.
What Is the Investment Thesis for LRSV?
Link Reservations Inc. presents a speculative investment opportunity within the niche market of medicinal mushroom and CBD wellness products. With a current market capitalization of $0.00B and a negative P/E ratio of -7.56, the company's financial performance indicates it is not yet profitable. The company's success hinges on its ability to effectively market and distribute its products in the competitive European and US markets. Key growth catalysts include expanding its product line and securing strategic partnerships. However, potential risks include regulatory hurdles in the CBD market and competition from larger, more established players. Investors should carefully consider the high beta of -9.69, indicating significant volatility.
Based on FMP financials and quantitative analysis
LRSV Key Highlights
Market Cap of $0.00B reflects the company's small size and early stage.
- P/E Ratio of -7.56 indicates the company is currently unprofitable.
- Beta of -9.69 suggests high volatility compared to the market.
- Focus on CBD products for both humans and pets targets a growing wellness market.
- Geographic presence in both Europe and the United States provides market diversification.
Who Are LRSV's Competitors?
LRSV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MEDS TRxADE HEALTH, Inc. | $3.68 | -9.36% | $9.65M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | — |
| NEUP Neuphoria Therapeutics Inc. | $3.47 | -1.14% | $18.8M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | — |
| PETS PetMed Express, Inc. | $1.36 | -0.73% | $29.1M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LRSV's Key Strengths?
Focus on high-growth CBD and medicinal mushroom markets.
- Products for both humans and pets diversifies customer base.
- Presence in both Europe and United States provides market access.
- Established brand in the niche wellness sector.
What Are LRSV's Weaknesses?
Small market capitalization limits access to capital.
- Negative P/E ratio indicates current unprofitability.
- High beta suggests significant stock volatility.
- Limited brand recognition compared to larger competitors.
What Are the Key Risks for LRSV?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Evolving regulatory landscape for CBD products in Europe and the United States.
- Intense competition from larger, more established players in the wellness sector.
- Fluctuations in raw material prices, particularly for hemp-derived CBD.
- Negative publicity regarding the safety and efficacy of CBD products.
- Limited access to capital due to small market capitalization.
What Are LRSV's Competitive Advantages?
- Proprietary formulations of CBD and medicinal mushroom products.
- Established presence in both European and United States markets.
- Focus on both human and pet wellness products.
- Brand reputation for quality and efficacy.
What Does LRSV Do?
Link Reservations Inc., originally incorporated as Vendum Batteries, Inc. in 2006, transitioned to Link Reservations Inc. in May 2015 to focus on the burgeoning wellness market. Based in Kington, United Kingdom, the company develops and markets medicinal mushroom and cannabidiol (CBD) wellness products. Its product line includes hemp-based CBD products tailored for cats, dogs, and horses, alongside offerings for humans. The company strategically targets both the European and United States markets, aiming to capitalize on the increasing consumer interest in alternative wellness solutions for both themselves and their pets. By focusing on specialty CBD products, Link Reservations aims to carve out a niche within the broader drug manufacturing industry, emphasizing natural and alternative health options.
What Products and Services Does LRSV Offer?
- Develops medicinal mushroom wellness products.
- Markets medicinal mushroom wellness products.
- Develops cannabidiol (CBD) wellness products.
- Markets cannabidiol (CBD) wellness products.
- Offers hemp-based CBD products for cats.
- Offers hemp-based CBD products for dogs.
- Offers hemp-based CBD products for horses.
- Offers hemp-based CBD products for humans.
How Does LRSV Make Money?
- Develops and formulates CBD and medicinal mushroom products.
- Markets products directly to consumers through online channels.
- Distributes products through retail partnerships.
- Generates revenue through product sales.
What Industry Does LRSV Operate In?
Link Reservations Inc. operates within the rapidly expanding market for specialty and generic drugs, focusing on the niche segment of medicinal mushroom and CBD wellness products. The industry is characterized by increasing consumer demand for alternative and natural health solutions. However, the market is also highly competitive, with numerous players vying for market share. Regulatory landscapes in both Europe and the United States are evolving, creating both opportunities and challenges for companies like Link Reservations Inc. The company's success depends on its ability to navigate these complexities and differentiate itself from competitors.
Who Are LRSV's Key Customers?
- Individuals seeking wellness products.
- Pet owners looking for CBD solutions for their animals.
- Retailers and distributors in the health and wellness sector.
- Consumers interested in alternative health remedies.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for Link Reservations Inc. stands at 3.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -33.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -8.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.08 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -13.2%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Link Reservations Inc. operates in the Healthcare sector. It is headquartered in Kington, GB. The company is led by CEO Joe Gutierrez. LRSV has traded publicly since 2016.
Financial Health
Link Reservations Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 2.75 places it in the grey zone, a middle ground that warrants monitoring.
LRSV Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
LRSV Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
LRSV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for LRSV.
Price Targets
Wall Street price target analysis for LRSV.
LRSV MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for LRSV; grades run from A+ (80-100) to F (below 30).
Leadership: Joe Gutierrez
CEO
Joe Gutierrez serves as the CEO of Link Reservations Inc. His background includes experience in business development and strategic management. He has been involved in guiding the company's transition towards the medicinal mushroom and CBD wellness markets. His expertise lies in identifying growth opportunities and implementing strategies to expand the company's market presence. He is focused on driving innovation and ensuring the quality and efficacy of Link Reservations Inc.'s products.
Track Record: Under Joe Gutierrez's leadership, Link Reservations Inc. has focused on developing and marketing CBD products for both humans and pets. Key milestones include expanding the product line and establishing a presence in both the European and United States markets. He has overseen the company's efforts to navigate the evolving regulatory landscape and build brand awareness in the competitive wellness sector.
LRSV OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Link Reservations Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and may be subject to greater risks.
- OTC Tier: OTC Other
- Limited Financial Disclosure: OTC Other companies may have limited financial disclosure, making it difficult to assess their financial health.
- Low Liquidity: Trading volume may be low, leading to wider bid-ask spreads and price volatility.
- Regulatory Uncertainty: The OTC market is subject to less regulatory oversight than major exchanges.
- Potential for Fraud: The lack of stringent listing requirements increases the risk of fraudulent or manipulative activities.
- Going Concern Risk: Companies in the OTC Other tier may face a higher risk of financial distress or bankruptcy.
- Verify the company's registration and compliance with regulatory requirements.
- Review the company's financial statements, if available, and assess its financial health.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's market capitalization and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Company has been in operation since 2006.
- Focus on developing and marketing CBD products for humans and pets.
- Presence in both European and United States markets.
- CEO listed with some background information.
What Investors Ask About Link Reservations Inc. (LRSV) — Healthcare
What does Link Reservations Inc. do?
Link Reservations Inc. develops and markets medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets. The company focuses on hemp-based CBD products, offering formulations for cats, dogs, horses, and humans.
What are the main risks for LRSV?
Link Reservations Inc. faces several key risks, including the evolving regulatory landscape for CBD products in both Europe and the United States.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- Financial data is limited for this company.